+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Candida Diagnostics Market 2024: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - US, Europe, Japan - Hospitals, Commercial and Public Health Labs, POC Locations

  • PDF Icon

    Report

  • August 2024
  • Region: Europe, Japan, United States
  • VPG Market Research
  • ID: 5995554
Description Jump to:
The report presents a detailed analysis of the Candida diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology are reviewed.

The report provides the 5-year test volume and sales forecasts by country for the following market segments:
  • Hospitals
  • Commercial/Private Labs
  • Physician Offices
  • Public Health Labs

Related Topics

Related Reports

2024-2028 Global Candida Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Candida Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures - Hospitals, Blood Banks, Commercial Labs, POC Locations - Product Image

2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures - Hospitals, Blood Banks, Commercial Labs, POC Locations

  • Report
  • 320 Pages
  • Global
From
Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With Analysis and Executive Guides 2024 - 2028 - Product Image

Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With Analysis and Executive Guides 2024 - 2028

  • Report
  • 670 Pages
  • Global
From
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 2024 - Product Image

The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 2024

  • Report
  • 620 Pages
  • Global
From
Point-Of-Care Molecular Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Point-Of-Care Molecular Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From

About the Market

The Candida Test market is a subset of the Infectious Disease Testing market. It is used to detect the presence of Candida, a type of fungus that can cause a variety of infections. Candida tests are used to diagnose and monitor the progression of Candida infections, as well as to determine the effectiveness of treatment. Tests may be performed on blood, urine, or other body fluids, and may include culture, antigen, and antibody tests. The Candida Test market is driven by the increasing prevalence of Candida infections, as well as the need for accurate and timely diagnosis and treatment. The market is expected to grow in the coming years, as new technologies and treatments are developed. Some companies in the Candida Test market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, Hologic, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.